• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿嘧啶及其他启动剂对N-丁基-N-(4-羟基丁基)亚硝胺引发的F344大鼠膀胱上皮病变发展的累加效应。

Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.

作者信息

de Camargo J L, Shirai T, Kato T, Asamoto M, Fukushima S

机构信息

First Department of Pathology, Nagoya City University Medical School.

出版信息

Jpn J Cancer Res. 1991 Nov;82(11):1220-5. doi: 10.1111/j.1349-7006.1991.tb01784.x.

DOI:10.1111/j.1349-7006.1991.tb01784.x
PMID:1752781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5918328/
Abstract

Five non-genotoxic chemicals previously demonstrated to be bladder cancer promoters in 36-week in vivo assays for carcinogenesis were reevaluated in a 20-week experiment in order to assess the summation influence of dietary uracil, a component of RNA, on the development of (pre)neoplastic lesions. The test chemicals, sodium bicarbonate, sodium L-ascorbate, sodium citrate, butylated hydroxytoluene and ethoxyquin, were mixed into the diet at concentrations of 3%, 5%, 5%, 1% and 0.8%, respectively, and administered to male F344 rats after initiation with 0.05% N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) in their drinking water for 4 weeks. The test chemicals were given from the 4th to the 8th and the 11th to 20th experimental weeks, uracil being administered at the level of 3% in the diet during the intervening period. Rats in the control group received only BBN and uracil. All animals were killed at week 20 and the bladders were evaluated for the occurrence of putative preneoplastic papillary or nodular (PN) hyperplasia and tumors. Significant increase in the occurrence of PN hyperplasia was observed in all groups initiated with BBN and fed uracil and test chemicals. Quantitative values for papillomas were also significantly increased except in the ethoxyquin-treated group. The results confirm that uracil given in the middle of the post-initiation stage enhances the promoting activity of chemicals and suggest that the use of this chemical might be useful to reduce the duration of current bioassays for bladder chemical carcinogens.

摘要

五种先前在为期36周的体内致癌试验中被证明为膀胱癌促进剂的非基因毒性化学物质,在一项为期20周的实验中重新进行了评估,以评估RNA成分尿嘧啶对(癌)前病变发展的综合影响。受试化学物质,碳酸氢钠、L-抗坏血酸钠、柠檬酸钠、丁基羟基甲苯和乙氧喹,分别以3%、5%、5%、1%和0.8%的浓度混入饲料中,并在雄性F344大鼠饮用含0.05% N-丁基-N-(4-羟基丁基)亚硝胺(BBN)的水4周启动致癌过程后给予。受试化学物质在实验第4至8周以及第11至20周给予,在此期间尿嘧啶以3%的水平添加到饲料中。对照组大鼠仅接受BBN和尿嘧啶。所有动物在第20周处死,并对膀胱进行评估,以确定是否存在假定的癌前乳头状或结节状(PN)增生及肿瘤。在所有用BBN启动并喂食尿嘧啶和受试化学物质的组中,均观察到PN增生发生率显著增加。除乙氧喹处理组外,乳头状瘤的定量值也显著增加。结果证实,在启动后阶段中期给予尿嘧啶可增强化学物质的促进活性,并表明使用这种化学物质可能有助于缩短当前膀胱化学致癌物生物测定的持续时间。

相似文献

1
Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.尿嘧啶及其他启动剂对N-丁基-N-(4-羟基丁基)亚硝胺引发的F344大鼠膀胱上皮病变发展的累加效应。
Jpn J Cancer Res. 1991 Nov;82(11):1220-5. doi: 10.1111/j.1349-7006.1991.tb01784.x.
2
Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.尿嘧啶对由N-丁基-N-(4-羟丁基)亚硝胺引发的F344大鼠膀胱癌两阶段和多阶段模型的累加效应。
Carcinogenesis. 1988 Nov;9(11):1981-5. doi: 10.1093/carcin/9.11.1981.
3
Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats.丁基羟基茴香醚和丁基羟基甲苯对大鼠两阶段膀胱致癌作用的促进活动以及对大鼠肝脏中γ-谷氨酰转肽酶阳性灶发展的抑制作用。
Carcinogenesis. 1983;4(7):895-9. doi: 10.1093/carcin/4.7.895.
4
Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin for promotion of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.丁基羟基茴香醚、丁基羟基甲苯和乙氧喹对N-丁基-N-(4-羟基丁基)亚硝胺引发、单侧输尿管结扎大鼠膀胱致癌作用的剂量依赖性影响。
Cancer Lett. 1987 Jan;34(1):83-90. doi: 10.1016/0304-3835(87)90077-2.
5
Differences in cell proliferation and apoptosis between reversible and irreversible mucosal lesions associated with uracil-induced urolithiasis in N-butyl-N-(4-hydroxybutyl)nitrosamine-pretreated.
Carcinogenesis. 1995 Mar;16(3):501-5. doi: 10.1093/carcin/16.3.501.
6
Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine.抗坏血酸、异抗坏血酸钠和乙氧喹对用N-丁基-N-(4-羟基丁基)亚硝胺引发的大鼠肿瘤性病变的促进作用。
Cancer Lett. 1984 May;23(1):29-37. doi: 10.1016/0304-3835(84)90058-2.
7
Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.在N-丁基-N-(4-羟基丁基)亚硝胺引发、单侧输尿管结扎的大鼠中对膀胱癌发生启动子的短期筛选。
Jpn J Cancer Res. 1985 Sep;76(9):828-34.
8
Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis.药物、食品添加剂及天然产物作为大鼠膀胱癌发生的促进剂
IARC Sci Publ. 1984(56):399-407.
9
Effects of uracil calculi on cell growth and apoptosis in the BBN-initiated Wistar rat urinary bladder mucosa.尿嘧啶结石对BBN诱导的Wistar大鼠膀胱黏膜细胞生长和凋亡的影响。
Teratog Carcinog Mutagen. 1999;19(4):293-303. doi: 10.1002/(sici)1520-6866(1999)19:4<293::aid-tcm6>3.3.co;2-r.
10
Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.鸟氨酸脱羧酶抑制剂1,3 - 二氨基丙烷对N-丁基-N-(4-羟丁基)亚硝胺引发的大鼠二阶段膀胱致癌作用的抑制效果
Carcinogenesis. 2000 Feb;21(2):195-203. doi: 10.1093/carcin/21.2.195.

引用本文的文献

1
Synergism of environmental carcinogens and promoters on bladder cancer development initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine in F344 rats.环境致癌物与促癌剂对F344大鼠中由N-丁基-N-(4-羟丁基)亚硝胺引发的膀胱癌发展的协同作用。
Jpn J Cancer Res. 1992 Sep;83(9):955-63. doi: 10.1111/j.1349-7006.1992.tb02007.x.

本文引用的文献

1
Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats.
Acta Pathol Jpn. 1982 Mar;32(2):243-50. doi: 10.1111/j.1440-1827.1982.tb02045.x.
2
Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.启动子对N-丁基-N-(4-羟基丁基)亚硝胺诱导大鼠膀胱致癌作用的影响。
Environ Health Perspect. 1983 Apr;50:61-9. doi: 10.1289/ehp.835061.
3
Capability of urinary components to enhance ornithine decarboxylase activity and promote urothelial tumorigenicity.
Cancer Res. 1983 Apr;43(4):1774-82.
4
Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine.抗坏血酸、异抗坏血酸钠和乙氧喹对用N-丁基-N-(4-羟基丁基)亚硝胺引发的大鼠肿瘤性病变的促进作用。
Cancer Lett. 1984 May;23(1):29-37. doi: 10.1016/0304-3835(84)90058-2.
5
Extracellular Na+ and initiation of DNA synthesis: role of intracellular pH and K+.细胞外钠离子与DNA合成起始:细胞内pH值和钾离子的作用
J Cell Biol. 1984 Mar;98(3):1082-9. doi: 10.1083/jcb.98.3.1082.
6
Promoting effects of various chemicals in rat urinary bladder carcinogenesis initiated by N-nitroso-n-butyl-(4-hydroxybutyl)amine.
Food Chem Toxicol. 1983 Feb;21(1):59-68. doi: 10.1016/0278-6915(83)90269-7.
7
Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats.丁基羟基茴香醚和丁基羟基甲苯对大鼠两阶段膀胱致癌作用的促进活动以及对大鼠肝脏中γ-谷氨酰转肽酶阳性灶发展的抑制作用。
Carcinogenesis. 1983;4(7):895-9. doi: 10.1093/carcin/4.7.895.
8
Histogenesis of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.N-丁基-N-(4-羟基丁基)亚硝胺诱导大鼠膀胱肿瘤的组织发生
Gan. 1969 Aug;60(4):401-10.
9
Multi-stage carcinogenesis in the urinary bladder.膀胱的多阶段致癌作用。
Food Chem Toxicol. 1985 Apr-May;23(4-5):521-8. doi: 10.1016/0278-6915(85)90146-2.
10
Uracil-induced urolithiasis and the development of reversible papillomatosis in the urinary bladder of F344 rats.尿嘧啶诱导F344大鼠膀胱尿石症及可逆性乳头状瘤病的发生
Cancer Res. 1986 Apr;46(4 Pt 2):2062-7.